ARCHIVES

Enzalutamide Reduced Risk of Progression By 81 Percent in Metastatic Prostate Cancer

This article is from The Cancer Letter archive.

Vol. 37 No. 6 | June 27, 2014

Download PDF Visit The Full Archive

Related Articles

ONF Invites Applications for Fatigue Research

April 19, 1996

Clinical Trials, Centers Would Be First In Line For Money Added To Budget, Broder Tells Congress

March 31, 1989

The Raghavan Experiment: With $500 Million to Draw On, An Iconoclast Invents Rational Care for a Gigantic System

January 4, 2013

Senate Kills Plan to Increase Tax On Higher Tar, Nicotine Cigarettes

August 13, 1976

FDA Approves HPV Test

April 25, 2003

House, Senate Agree On $1.91 Billion NCI Appropriations

September 30, 1994